Dutch Analysis Raises Questions About COVID-19 Vaccine Impact, Reports Unexplained Excess Mortality
Amsterdam, Netherlands – A newly released document is sparking debate in the Netherlands regarding the safety and effectiveness of COVID-19 vaccines, alongside a significant and unexplained rise in excess mortality since the start of the vaccination campaign.The analysis, which meticulously examines Dutch data, suggests the initial impact of COVID-19 was limited, and questions whether the benefits of vaccination outweigh potential harms, especially when considered across different age groups.
The document points to the initial “coronagolf” in May 2020,which saw few deaths,followed by a summer with minimal mortality. The authors state the vaccine rollout arrived “as mustard after the meal,” implying it came after the most critical period had passed.
A key finding centers around an unexplained surge in mortality beginning in March 2021, coinciding with the start of vaccinations. Instead of the anticipated decrease in deaths, mortality rose to approximately 13,000 per year – more than double the figure from the first wave of the pandemic. This excess mortality now totals 60,000 cases and continues to persist.
Data presented challenges the narrative of widespread vaccine effectiveness.In March 2021, vaccinated individuals reportedly died of COVID-19 at a rate 50% higher than unvaccinated individuals, a figure the analysis attributes to the initial six-week period where vaccine protection was not yet optimal. During the Delta wave in the autumn of 2021, 75% of COVID-19 deaths occurred among vaccinated individuals, despite an 80% vaccination rate. This suggests a vaccine effectiveness of only around 25% during that period, with 5,874 vaccinated people dying compared to the first wave when no one was vaccinated.
The analysis also references a study by NIVEL, a Dutch research institute, which initially indicated a potential causal link between vaccination and overmortality.Their calculations suggested a 20% increase in mortality for vaccinated individuals, which would equate to 38,600 extra deaths among the unvaccinated – roughly 1 in 50 unvaccinated people dying as a consequence of others being vaccinated. NIVEL subsequently took the calculations offline.
The Balance Sheet:
The document presents a cost-benefit analysis:
* COVID-19 Impact: 22,000 deaths, representing approximately 11,000 years of life lost, with the authors noting these were likely the most vulnerable years of life.
* Vaccination Effects: A potential 1,500 deaths (based on 25% effectiveness), equating to roughly 750 years of life lost.
* Unexplained Excess Mortality: 60,000 cases since vaccination began, potentially representing 300,000 lost years of life (calculated at 5 years per death), and a shift in mortality from older to younger generations.
Conclusions and Recommendations:
The authors conclude that:
- The initial impact of the coronavirus was comparable to a severe flu.
- The “final boost” character of the pandemic limited it’s overall impact.
- Vaccination may have saved 750 years of life.
- The 60,000 cases of unexplained excess mortality since vaccination began represent a significant concern.
- Even if only a quarter of the excess mortality is attributable to vaccination, it may not outweigh the lives saved.
The document argues that vaccination should only be recommended for the elderly, while acknowledging the potential health vulnerabilities that may preclude vaccination for this group. It calls for a detailed risk-benefit analysis per age group to determine appropriate vaccination eligibility.
Ultimately, the authors advocate for a reevaluation of the Netherlands’ vaccination policy, emphasizing the need to weigh risks and benefits based on the actual impact of COVID-19 and the observed excess mortality as the vaccination campaign’s launch.
